Hassan MM - Search Results

1

Prognostic indicators and treatment outcome in 94 cases of fibrolamellar hepatocellular carcinoma.

Kaseb AO, Shama M, Sahin IH, Nooka A, Hassabo HM, Vauthey JN, Aloia T, Abbruzzese JL, Subbiah IM, Janku F, Curley S, Hassan MM. Kaseb AO, et al. Among authors: hassan mm. Oncology. 2013;85(4):197-203. doi: 10.1159/000354698. Epub 2013 Sep 19. Oncology. 2013. PMID: 24051705 Free PMC article.

2

Mutagen sensitivity as a susceptibility marker for human hepatocellular carcinoma.

Wu X, Gu J, Patt Y, Hassan M, Spitz MR, Beasley RP, Hwang LY. Wu X, et al. Cancer Epidemiol Biomarkers Prev. 1998 Jul;7(7):567-70. Cancer Epidemiol Biomarkers Prev. 1998. PMID: 9681523

3

Durable clinical response of refractory hepatocellular carcinoma to orally administered thalidomide.

Patt YZ, Hassan MM, Lozano RD, Ellis LM, Peterson JA, Waugh KA. Patt YZ, et al. Among authors: hassan mm. Am J Clin Oncol. 2000 Jun;23(3):319-21. doi: 10.1097/00000421-200006000-00023. Am J Clin Oncol. 2000. PMID: 10857902

4

The role of hepatitis C in hepatocellular carcinoma: a case control study among Egyptian patients.

Hassan MM, Zaghloul AS, El-Serag HB, Soliman O, Patt YZ, Chappell CL, Beasley RP, Hwang LY. Hassan MM, et al. J Clin Gastroenterol. 2001 Aug;33(2):123-6. doi: 10.1097/00004836-200108000-00006. J Clin Gastroenterol. 2001. PMID: 11468438

5

Phase II trial of cisplatin, interferon alpha-2b, doxorubicin, and 5-fluorouracil for biliary tract cancer.

Patt YZ, Hassan MM, Lozano RD, Waugh KA, Hoque AM, Frome AI, Lahoti S, Ellis L, Vauthey JN, Curley SA, Schnirer II, Raijman I. Patt YZ, et al. Among authors: hassan mm. Clin Cancer Res. 2001 Nov;7(11):3375-80. Clin Cancer Res. 2001. PMID: 11705850 Clinical Trial.

6

DNA adducts, genetic polymorphisms, and K-ras mutation in human pancreatic cancer.

Li D, Firozi PF, Zhang W, Shen J, DiGiovanni J, Lau S, Evans D, Friess H, Hassan M, Abbruzzese JL. Li D, et al. Mutat Res. 2002 Jan 15;513(1-2):37-48. doi: 10.1016/s1383-5718(01)00291-1. Mutat Res. 2002. PMID: 11719088

7

Rising prevalence of hepatitis C virus infection among patients recently diagnosed with hepatocellular carcinoma in the United States.

Hassan MM, Frome A, Patt YZ, El-Serag HB. Hassan MM, et al. J Clin Gastroenterol. 2002 Sep;35(3):266-9. doi: 10.1097/00004836-200209000-00013. J Clin Gastroenterol. 2002. PMID: 12192205

8

Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus.

Hassan MM, Hwang LY, Hatten CJ, Swaim M, Li D, Abbruzzese JL, Beasley P, Patt YZ. Hassan MM, et al. Hepatology. 2002 Nov;36(5):1206-13. doi: 10.1053/jhep.2002.36780. Hepatology. 2002. PMID: 12395331

9

Phase II trial of systemic continuous fluorouracil and subcutaneous recombinant interferon Alfa-2b for treatment of hepatocellular carcinoma.

Patt YZ, Hassan MM, Lozano RD, Brown TD, Vauthey JN, Curley SA, Ellis LM. Patt YZ, et al. Among authors: hassan mm. J Clin Oncol. 2003 Feb 1;21(3):421-7. doi: 10.1200/JCO.2003.10.103. J Clin Oncol. 2003. PMID: 12560429 Clinical Trial.

10

Oral capecitabine for the treatment of hepatocellular carcinoma, cholangiocarcinoma, and gallbladder carcinoma.

Patt YZ, Hassan MM, Aguayo A, Nooka AK, Lozano RD, Curley SA, Vauthey JN, Ellis LM, Schnirer II, Wolff RA, Charnsangavej C, Brown TD. Patt YZ, et al. Among authors: hassan mm. Cancer. 2004 Aug 1;101(3):578-86. doi: 10.1002/cncr.20368. Cancer. 2004. PMID: 15274071 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

774 results

Search Page

Filters